ClinicalTrials.gg
Not yet recruitingNCT07949279Updated Nov 19, 2026

Movement Patterns and Balance in People With Lumbar Radiculopathy

An observational study in Lumbar Radiculopathy, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 30 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Cairo University · Observational

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
66
Ages
30 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 36 studies in Radiculopathy by Cairo University — 22 open to participants now, 22 under way, none of them phase 3. Radiculopathy · Cairo University.

Started
2026
with 12 others
Observational
9 of 36
7 open now
Primary completion
2027-02
later than 19 of 21 live
Registered
36th of 36
by date

Among the 36 studies in Radiculopathy by Cairo University, this one is one of 13 that started in 2026, is one of 9 observational ones, reaches primary completion later than 19 of the 21 other live ones, and was the 36th registered.

Radiculopathy

488 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.

Browse Radiculopathy studies →

Open to participants now

22 of the 36 studies in Radiculopathy by Cairo University are open now, in 1 country. Recruiting first, the newest first:

16 more — sign in →

By country, each count listing its studies:

All 22 open studies →

Where they have run

Who these studies take

Of the 79 Radiculopathy studies recruiting now, 23 (29%) set no upper age limit and 48 (61%) stop at 75 or younger; 3 take children under 18; 7 take healthy volunteers.

This study: 30 Years to 50 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies in Radiculopathy by Cairo University, or all of them as a file.
02

Study summary

This study aims to investigate the relationship between dynamic lumbopelvic kinematics and postural stability in individuals with lumbar radiculopathy and to compare these findings with those of healthy individuals.

The study will include individuals diagnosed with lumbar radiculopathy and healthy participants. Video recordings of participants will be obtained during three functional tasks: forward bending, step-up, and sit-to-stand. The recorded videos will subsequently be analyzed using Kinovea software to assess lumbopelvic movement angles, including pelvic tilt angle, lumbar lordosis angle, and trunk inclination angle. Postural stability will be assessed separately using the TOGU balance assessment system.

The study will investigate the correlations between each kinematic variable and the TOGU Stability Index. Additionally, differences in dynamic lumbopelvic movement angles and postural stability between individuals with lumbar radiculopathy and healthy participants will be examined.

The findings may contribute to a better understanding of dynamic movement patterns and postural stability in individuals with lumbar radiculopathy.

03

Conditions studied

  • Lumbar Radiculopathy

Browse trials for

Keywords

  • Lumbar Radiculopathy
  • Lumbopelvic Kinematics
  • Postural Stability
  • Dynamic Movement
  • Balance
04

Who can participate

Ages eligible
30 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population will consist of 66 participants, including 33 individuals with lumbar radiculopathy and 33 healthy control participants. Participants will be recruited from the outpatient clinics of Cairo University and Suez University, as well as private clinics in Alexandria, Egypt. Both male and female participants will be eligible. Healthy controls will be matched to the lumbar radiculopathy group according to age and sex.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants in the lumbar radiculopathy group must meet all of the following criteria:

  1. Clinical Diagnosis : Confirmed clinical and radiological (MRI) diagnosis of unilateral lumbar radiculopathy secondary to degenerative disc disease or disc herniation.
  2. Chronicity : Duration of symptoms for more than 3 consecutive months.
  3. Anatomical Levels : Nerve root compression localized to the L4-L5 or L5-S1 levels.
  4. Age Range : Chronological age between 30 and 50 years.
  5. Functional Autonomy :Ability to stand independently and perform the required functional tasks safely without assistive devices.
  6. (BMI) : Between 18.5 and 29.9 kg/m².
  7. Cognitive Ability : Ability to understand and follow verbal instructions, with a (MMSE) score of 24 or higher.

Healthy control participants must be between 30 and 50 years of age, have no history or clinical evidence of lumbar radiculopathy or relevant neurological or musculoskeletal disorders, and be able to perform the required functional tasks and balance assessment safely without assistive devices.

Exclusion criteria

Exclusion Criteria

Participants will be excluded if they meet any of the following criteria:

  1. Bilateral lumbar radiculopathy or acute spinal symptoms (duration less than 3 months).
  2. Previous history of spinal, pelvic, or major lower extremity orthopedic surgeries.
  3. Coexisting central neurological disorders independently disrupting motor control (e.g., stroke or Parkinson's disease).
  4. Diabetic peripheral neuropathy or severe peripheral vascular diseases impairing joint position sense.
  5. Vestibular or uncorrected visual disorders directly affecting peripheral balance systems.
  6. Recent acute lower extremity musculoskeletal injuries (e.g., fractures or joint sprains within the past 6 months).
  7. Severe spinal deformities (e.g., structural scoliosis or high-grade spondylolisthesis).
  8. Coexisting piriformis syndrome.
  9. Use of medications affecting central nervous system or balance control (e.g., muscle relaxants, sedatives, or central analgesics) within 48 hours prior to testing.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
66 participants (estimated)
Target follow-up
01 Days
Patient registry
Yes

Groups and cohorts

  • Lumbar Radiculopathy Group

    Participants diagnosed with lumbar radiculopathy who will be assessed for dynamic lumbopelvic kinematics during functional tasks and postural stability.

  • Healthy Control Group

    Healthy individuals without lumbar radiculopathy who will have the same dynamic lumbopelvic kinematic and postural stability assessments as the lumbar radiculopathy group.

06

What researchers measure

Primary outcomes

  1. Correlation Between Pelvic Tilt Angle and TOGU Stability Index

    The correlation between pelvic tilt angle and postural stability will be investigated. Pelvic tilt angle will be assessed through video recordings obtained during three functional tasks: forward bending, step-up, and sit-to-stand. Each task will be performed three times, and the recorded videos will subsequently be analyzed using Kinovea software to determine the pelvic tilt angle. The mean angle across the three trials will be calculated separately for each task. Postural stability will be assessed using the assessment mode of the TOGU Balance Challenge Disc 2.0. Participants will perform three 20-second trials in a bilateral standing position with eyes open, with 10-second rest intervals between trials. The mean of the three Stability Index scores (range: 1-5) generated by the system will be used for analysis. Correlations between the mean pelvic tilt angle for each functional task and the mean TOGU Stability Index will then be examined.

    Time frame: At the baseline assessment (single assessment session).

Secondary outcomes

  1. Correlation Between Lumbar Lordosis Angle and TOGU Stability Index

    The correlation between lumbar lordosis angle and postural stability will be investigated. Lumbar lordosis angle will be assessed from video recordings obtained during three functional tasks: forward bending, step-up, and sit-to-stand. Each task will be performed three times, and the recorded videos will be analyzed using Kinovea software. The mean angle across the three trials will be calculated separately for each task and correlated with the mean TOGU Stability Index obtained from three 20-second trials.

    Time frame: At the baseline assessment (single assessment session).

  2. Correlation Between Trunk Inclination Angle and TOGU Stability Index

    The correlation between trunk inclination angle and postural stability will be investigated. Trunk inclination angle will be assessed from video recordings obtained during three functional tasks: forward bending, step-up, and sit-to-stand. Each task will be performed three times, and the recorded videos will be analyzed using Kinovea software. The mean angle across the three trials will be calculated separately for each task and correlated with the mean TOGU Stability Index obtained from three 20-second trials.

    Time frame: At the baseline assessment (single assessment session).

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Feb 2027, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2026
First posted
Nov 19, 2026
StartEst.
Dec 1, 2026
Primary completionEst.
Feb 28, 2027
CompletionEst.
Mar 1, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07949279
Lead sponsor
Cairo University
Responsible party
Mayar Magdy Ragaay Helmy (demonstrator, Cairo University) — Principal investigator
First posted
Nov 19, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Feb 28, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Mayar Magdy ragaay Helmy, BSc
Contact
mayarmagdy420@gmail.com
+201009885172

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion